Publication: 3910

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor–Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination

Citation:: JAMA Oncol vol 10 (3) 362-371

Year:: 2024
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: 3262 3390 3391
Children:: None

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:: AstraZeneca, Genentech
Grants:: U10CA180821, U10CA180882, UG1CA232760, UG1CA233302, UG1CA233327, UG1CA233329, UG1CA233339, U10CA180868 (NRG), UG1CA233180, UG1CA233193, UG1CA233373.

Corr. Author:
Authors:: Cynthia X. Ma Vera J. Suman Souzan Sanati Kiran Vij Meenakshi Anurag A. Marilyn Leitch Gary W. Unzeitig Jeremy Hoog Aranzazu Fernandez-Martinez Cheng Fan Richard A. Gibbs Mark A. Watson Travis J. Dockter Olwen Hahn Joseph M. Guenther Abigail Caudle Erika Crouch Amy Tiersten Monica Mita Wajeeha Razaq Tina J. Hieken Yang Wang Mothaffar F. Rimawi Anna Weiss Eric P. Winer Kelly K. Hunt Charles M. Perou Matthew J. Ellis Ann H. Partridge Lisa A. Carey

Networks:: CA016, KY015, LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NC007, LAPS-OK003, LAPS-TX011, LAPS-TX035, NEWMEXICO, NY021, NY167, TX041, TX190

Study: Alliance-A011106
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: